The U.S. Food and Drug Administration (FDA) has issued new draft guidance to reduce the use of non-human primates for certain monoclonal antibody (mAb) products. These laboratory-produced antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback